BR9810453A - Compostos que codificam proteìna protetorasemelhante a m de streptococcus equi e testespara os mesmos - Google Patents

Compostos que codificam proteìna protetorasemelhante a m de streptococcus equi e testespara os mesmos

Info

Publication number
BR9810453A
BR9810453A BR9810453-5A BR9810453A BR9810453A BR 9810453 A BR9810453 A BR 9810453A BR 9810453 A BR9810453 A BR 9810453A BR 9810453 A BR9810453 A BR 9810453A
Authority
BR
Brazil
Prior art keywords
compounds
streptococcus equi
amino acid
present
tests
Prior art date
Application number
BR9810453-5A
Other languages
English (en)
Inventor
John F Timoney
Sergey Artiushin
Original Assignee
John F Timoney
Sergey Artiushin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John F Timoney, Sergey Artiushin filed Critical John F Timoney
Publication of BR9810453A publication Critical patent/BR9810453A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSTOS QUE CODIFICAM PROTEìNA PROTETORASEMELHANTE A M DE STREPTOCOCCUS EQUI E TESTESPARA OS MESMOS". A presente invenção refere-se, de modogeral, a compostos moleculares que codificam a proteína protetorasemelhante a M de Streptococcus equi (SeM), ao composto deaminoácido que é assim codificado e a composições correlatasque incorporam tanto os compostos de codificação quanto oscomponentes celulares que são codificados pelos mesmos. Porexemplo, as vacinas que utilizam os compostos de aminoácido ouvetores e linhagens de células úteis para fabricar os compostos deaminoácido descritos aqui são o assunto da presente invenção. Apresente invenção provê processos para estimular a respostaimune específica de S. equi em cavalos. Ela também fornecetestes de diagnóstico para Streptococcus equi.
BR9810453-5A 1997-06-24 1998-06-23 Compostos que codificam proteìna protetorasemelhante a m de streptococcus equi e testespara os mesmos BR9810453A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5057797P 1997-06-24 1997-06-24
PCT/US1998/012962 WO1998058945A1 (en) 1997-06-24 1998-06-23 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor
US09/103,664 US6458358B1 (en) 1997-06-24 1998-06-23 Compounds encoding the protective M-like protein of Streptococcus equi and assays therefor

Publications (1)

Publication Number Publication Date
BR9810453A true BR9810453A (pt) 2001-12-11

Family

ID=26728415

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810453-5A BR9810453A (pt) 1997-06-24 1998-06-23 Compostos que codificam proteìna protetorasemelhante a m de streptococcus equi e testespara os mesmos

Country Status (10)

Country Link
US (1) US6458358B1 (pt)
EP (1) EP0993469A1 (pt)
JP (1) JP2002512528A (pt)
KR (1) KR20010020529A (pt)
AU (1) AU8159498A (pt)
BR (1) BR9810453A (pt)
CA (1) CA2294468A1 (pt)
NO (1) NO996360L (pt)
PL (1) PL341030A1 (pt)
WO (1) WO1998058945A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201122121D0 (en) 2011-12-22 2012-02-01 Animal Health Trust Diagnostic test for bacterial pathogens
KR101694676B1 (ko) * 2015-12-10 2017-01-10 우진 비앤지 주식회사 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
IES960488A2 (en) 1996-07-03 1997-11-19 Trinity College Dublin Subunit Vaccine for Streptococcus Equi

Also Published As

Publication number Publication date
JP2002512528A (ja) 2002-04-23
NO996360D0 (no) 1999-12-21
CA2294468A1 (en) 1998-12-30
US6458358B1 (en) 2002-10-01
NO996360L (no) 2000-02-22
KR20010020529A (ko) 2001-03-15
WO1998058945A1 (en) 1998-12-30
AU8159498A (en) 1999-01-04
EP0993469A1 (en) 2000-04-19
WO1998058945A9 (en) 1999-04-15
PL341030A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
PT912176E (pt) Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
PT1071752E (pt) Polipeptidos especificos para cd19xcd3 e suas utilizacoes
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
EP1484339A3 (en) Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
BR9909472A (pt) Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
BRPI0414722A (pt) meios sem produto animal e processos para obtenção de uma toxina botulìnica
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
BR9801652A (pt) Resorcinil-triazinas
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
ATE489462T1 (de) Antimikrobielles polypeptid und nutzung davon
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
AU2383988A (en) Molecular decoyants and methods of use thereof
DE69834136D1 (de) Gefrierschutzprotein
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
BR0312889A (pt) Polipeptìdeo t20 peguilado
TR200400639T4 (tr) Donmaya-karşı proteinler, bunların üretimleri ve kullanımları
BR9810453A (pt) Compostos que codificam proteìna protetorasemelhante a m de streptococcus equi e testespara os mesmos
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
ES2188653T3 (es) Variantes de la dnasa i humana.
Ohtani et al. Further characterization of cysteine proteinase inhibitors purified from rat and human epidermis
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
BR9809405A (pt) Proteinase de streptococcus pneumoniae que degrada complemento humano c3
WO2000026246A3 (en) Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C07H 21/04; C07K 1/00; C12Q 1/68; C12N 1/20; C12N 1/14; C12N 5/00; C12N 5/06; C12N 5/08; C12N 5/10; A61K 39/00; A61K 39/02; A61K 39/09.

Ipc: C07K 14/315 (2006.01), A61K 39/00 (2006.01)

Ipc: C07K 14/315 (2006.01), A61K 39/00 (2006.01)